期刊文献+

用于抗体纯化工艺中除病毒膜的应用研究进展

Research Progress on the Application of Virus Removal Membranes in Antibody Purification Processes
下载PDF
导出
摘要 抗体类药物被作为治疗制剂、血液制品和免疫调节剂等,正成为生物医药领域的研究前沿。在抗体下游纯化工艺中常使用除病毒膜去除病毒颗粒,它保障了抗体类药物的卫生安全和患者的生命健康。本文综述了目前病毒过滤的分离机理以及除病毒膜的新型材料研究,对市售的除病毒过滤器性能参数简述概括,对膜技术应用于病毒过滤的挑战和困难进行了总结和展望。 Antibody-based drugs,used as therapeutic agents,blood products,and immunomodulators,are becoming a frontier in the biopharmaceutical field.In the downstream purification processes of antibodies,virus removal membranes are commonly employed to eliminate viral particles,ensuring the hygienic safety of antibody-based drugs and the health of patients.This review summarizes the current separation mechanisms of virus filtration and the research on novel materials for virus removal membranes.It also provides an overview of the performance parameters of commercially available virus removal filters and discusses the challenges and difficulties associated with applying membrane technology to virus filtration,along with future prospects.
作者 罗旭 叶卉 李泓 张玉忠 LUO Xu;YE Hui;LI Hong;ZHANG Yuzhong(State Key Laboratory of Separation Membrane and Processes,Sehool of Materials Science and Engineering,Tiangong University,Tianjin 300387,China)
出处 《山东化工》 CAS 2024年第19期153-157,共5页 Shandong Chemical Industry
关键词 除病毒膜 除病毒过滤器 抗体纯化 virus removal membrane virus filter antibody purification
  • 相关文献

参考文献10

二级参考文献99

  • 1包正琦,段丽娟,戴于栋,孙伟,田芳园,高建军.低pH孵放法对马破伤风免疫球蛋白F(ab′)2病毒灭活效果的验证[J].微生物学免疫学进展,2020(3):36-41. 被引量:2
  • 2李建兴,高林.影响紫外线空气消毒效果的因素分析[J].制冷与空调(四川),2006,20(3):86-89. 被引量:8
  • 3Schutyser M, Rupp R, Wideman J, et al. Dean vortex membrane microfiltration and diafiltration of rBDNF E. coli inclusion bodies [J]. Biotechnol Prog, 2002,18 (2) : 322.
  • 4Levesley J A, Hoare M. The effect of high frequency backflushing on the microfiltration of yeast homogenate suspensions for the recovery of soluble proteins [J]. J Membr Sci,1999,158:29.
  • 5Sundaram S, Auriemma M, Howard G, et al. Application of membrane filtration for removal of diminutive bioburden organisms in pharmaceutical products and processes [J]. PDA J Pharm Scl Technol, 1999,53:186.
  • 6Sundaram S. Lewis M, Eisenhuth J, et aL Method for qualifying microbial removal performance of 0. 1 micron rated filters. Part Ⅳ: Retention of hydrogenophaga pseudoflava (ATCC 700892) and Ralstonia pickettii (ATCC 700591) by 0. 2 and 0. 22 micron rated filters [J]. PDA d Pharm Sci Technol,2002,56(3):150.
  • 7Raman L P, Capocci T. Precise filtration for the pharmaceutical industry [J]. Filt Sep,2002,39:22.
  • 8Cruz P E, Peixoto C C, Devos K, et al. Characterization and downstream processing of HIV-1 core and virus-like-particles produced in serum free medium [J]. Enzyme Microb Technol, 2000,26 : 61.
  • 9Morao A, Brites Alves A M, Cardoso J P. Uhrafihration of demethylchlortetraeyeline industrial fermentation broths [J]. Sep Purif Technol, 2001.22- 23 : 459.
  • 10Brites Alves A M, Morao A, Cardoso J P. Isolation of antibiotics from industrial fermentation broths using membrane technology [J]. Desalination, 2002,148 : 181.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部